Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033824 · ClinicalTrials.gov registry record · NA
Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02033824 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 7 participants.
The verdict
NCT02033824, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of dHACM in reducing scar tissue formation in craniectomy patients as well as facilitating reoperation and repair. Specifically this study compares craniectomy without dHACM application to craniectomy with placement of dHACM between the galea and dura over dural suture line and/or exposed parenchyma.
Interventions
- OTHER dHACM
- PROCEDURE Craniectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-04 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02033824
The ClinicalTrials.gov registry entry for NCT02033824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which dHACM is the first listed.
NCT02033824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02033824 about?
NCT02033824 is a clinical study titled "Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring". The purpose of this study is to evaluate the effectiveness of dHACM in reducing scar tissue formation in craniectomy patients as well as facilitating reoperation and repair. Specifically this study compares craniectomy without dHACM application to craniectomy with placement of dHACM between the gale...
What is the current status of trial NCT02033824?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2014-04. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02033824?
The interventions under investigation include: dHACM (OTHER), Craniectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02033824?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.